NCT06714851 - Chondractiv Move on Activity-related Joint Discomfort | Biotech Hunter

Enrollment

144

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

May 9, 2025

Study Completion Date

May 9, 2025

Conditions

Joint; Derangement

Interventions

DIETARY_SUPPLEMENT

Chondractiv Move

The dietary supplement under study (Chondractiv Move) is a combination of 2 active ingredients: Hydrolyzed chicken cartilage and Rosehip extract at the dose of 1580 mg/day.

OTHER

Placebo

Placebo contains 100% maltodextrins as non-active agent at the dose of 1800 mg/day.

Trial Locations (1)

21000

Cen Experimental, Dijon